Safety and effectiveness of appropriately and inappropriately dosed rivaroxaban or apixaban versus warfarin in patients with atrial fibrillation: a cohort study with nested case–control analyses from UK primary care

Jun-22

AUTHORS : Antonio González-Pérez, Spanish Centre for Pharmacoepidemiologic Research (CEIFE), Almirante 28, 28004 Madrid, Spain – Email: agonzalez@ceife.es – Profile: http://www.ceife.es/quienes-somos.html

JOURNAL : BMJ Open

REFERENCE: 2022;12:e059311

DOI : 10.1136/bmjopen-2021-059311

Safety and effectiveness of appropriately and inappropriately dosed rivaroxaban or apixaban versus warfarin in patients with atrial fibrillation: a cohort study with nested case–control analyses from UK primary care

More publications

Association Between Type 2 Diabetes Onset Age and Risk of Cardiovascular Disease and Mortality: Two Cohort Studies from United Kingdom and Hong Kong

Characteristics of Patients With Atherosclerotic Cardiovascular Disease in Belgium and Current Treatment Patterns for the Management of Elevated LDL-C Levels

Unveiling unique clinical phenotypes of hip fracture patients and the temporal association with cardiovascular events